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Abstract
Neuropathic pain is severe chronic pain with no single source
and, for that reason, is difficult to treat. I review two treatments for
neuropathic pain: pharmacotherapy and mindfulness meditation. In
pharmacotherapy, psychotropic drugs are the main form of treatment.
Although it is currently the treatment of choice, relying solely on
drugs can result in unwanted side effects, including drug tolerance.
Mindfulness meditation, a therapy designed to help the patient
achieve self-understanding and self-regulation, avoids these effects.
For these reasons, mindfulness meditation should be recommended as
an alternative to psychotropic drugs when treating neuropathic pain.
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Treating Neuropathic Pain: Mindfulness Meditation Is More
Effective Than Pharmacotherapy
Physical pain can be viewed as warning the body of tissue damage
and helping it avoid further harm until the damaged tissue is repaired.
When stimuli cross the threshold of nociceptor primary sensory
neurons (PSNs), pain is elicited (Woolf & Mannion, 1999). These
neurons have receptive fields throughout the surface of the body and
eventually synapse in the dorsal horn of the spinal cord (Hogan, 2010).
Neuropathic pain (also known as chronic pain) is the result of
damaged PSNs. Damage can occur in the peripheral or central nervous
system and results in spontaneous pain, pain hypersensitivity, or
both (Woolf & Mannion, 1999). The complexity of neuropathic pain
is increased by the large number of causes, including infection,
trauma, metabolic abnormality, chemotherapy, surgery, irradiation,
neurotoxins, inherited neurodegeneration, nerve compression,
inflammation, and tumor infiltration (Dworkin et al., 2003). The
multiplicity of origins and manifestations of neuropathic pain make it
difficult to treat and, thus far, impossible to cure.
Chronic pain is not only physically limiting but produces severe
psychological repercussions as well. Gore, Brandenburg, Hoffman, Tai,
and Stacey (2006) surveyed 265 patients with neuropathic pain and
found that patients not only reported substantial, daily pain but also
increased anxiety, depression, sleep disturbance, and impaired quality
of life because of the unrelieved pain. This chronic pain compromises
all aspects of the lives of those affected and the lives of their significant
others (Turk, Wilson, & Cahana, 2011).
The pharmacotherapeutic treatments for neuropathic pain have
limited effectiveness and usually result in a host of unwanted side
effects (Dworkin et al., 2003). Mindfulness meditation, an inexpensive,
nondrug treatment, has been shown to relieve the symptoms of
chronic pain without harmful side effects (Kabat-Zinn, Lipworth,
& Burney, 1985). It also effectively mitigates the psychological
consequences of neuropathic pain (Pepping, Walters, Davis, &
O’Donovan, 2016). Because of these benefits, mindfulness meditation
should be considered a viable alternative to pharmacotherapy.
Limitations of Pharmacotherapy
Currently accepted medical alternatives to pharmacotherapy
https://scholarsarchive.byu.edu/intuition/vol12/iss2/6
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include surgery, neuro-augmentation, somatic, behavioral, and
rehabilitative treatments, though the effectiveness of these methods
remains inconsistent (Turk et al., 2011). If a particular medication
is ineffective in treating neuropathic pain, rather than turning to
alternative forms of treatment, the currently accepted approach is
to continue prescribing medication until an effective one is found
(Dworkin et al., 2003; Moulin et al., 2007). One problem with this
approach is the adverse side effects of this medication. Another that
will be considered is the diminished effect of drugs with continued use
(drug tolerance).
Side Effects of Medication
Adverse side effects associated with analgesic drugs include
dizziness, gastrointestinal problems, inflammation, skin reactions,
constipation, sedation, and nausea (Dworkin et al., 2003). These
effects may be exacerbated when multiple medications are prescribed,
especially since the average number of medications taken each week
to manage chronic pain is 3.8 (Gore et al., 2006). These medications
include opioids, anti-inflammatory drugs, antidepressants,
anticonvulsants, skeletal muscle relaxants, and topical agents (Turk
et al., 2011). Treating the many symptoms of neuropathic pain with
multiple prescriptions is costly, inefficient, and invites a host of
unwelcomed side effects.
Poor and Diminishing Effect of Analgesics
Another limitation is the growing ineffectiveness of drugs. Because
neuropathic pain is chronic, it outlasts the interval in which drugs may
be effective (Dworkin et al., 2003). Moreover, to restore effectiveness,
larger dosages are required, thereby intensifying the side effects
(Trang et al., 2015). Kingery (1997) reviewed 92 drug trials for 48
different medications for neuropathic pain and concluded that none
produced more than minimal long-term effectiveness.
Benefits of Mindfulness Meditation
A preferable alternative to pharmacotherapy is mindfulness
meditation, the “intentional self-regulation of attention to present
moment experience, coupled with a non-judgmental and accepting
stance toward whatever may arise” (Pepping et al., 2016, p. 1).
Mindfulness meditation differs from traditional pain-reduction
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treatments in its primary goals of self-regulation, self-liberation, and
self-exploration, all of which conduce to self-understanding (Shapiro,
1992). The use of mindfulness meditation may not only reduce pain
but also prevent pain from interfering with daily life.
Mindfulness meditation is most commonly practiced through
mindfulness-based stress reduction (MBSR), an 8¬¬–10 week program
that includes mindful scanning of one’s body, sitting and walking
forms of meditation, and basic yoga (Shigaki, Glass, & Schopp, 2006).
The MBSR coach encourages patients to be increasingly mindful of
everyday activities (to be “aware of the moment”) and to practice
meditation between sessions (Kabat-Zinn, 1990).
A Holistic Approach
Mindfulness meditation provides a focus on the psychological
problems associated with neuropathic pain as well as relief from
the pain itself (Kabat-Zinn et al., 1985; Pepping et al., 2016). When
Kabat-Zinn et al. (1985) analyzed the effectiveness of mindfulness
meditation in 90 chronic pain patients enrolled in a 10-week stress
reduction and relaxation program, they found significant reductions
in present-moment pain, negative body image, pain-induced
inhibition of activity, mood disturbance, and psychological symptoms.
More recently, Pepping and colleagues (2016) reported that, of 190
participants whom they interviewed, the primary reason given for
commencing and continuing mindfulness meditation was to alleviate
emotional stress and enhance emotional regulation.
Effectiveness
Not only is mindfulness meditation as effective in treating
neuropathic pain as traditional psychopharmacological treatments,
but is, in some cases, more effective than comparable psychological
treatments such as cognitive behavior therapy (CBT). This is
especially noticeable in terms of effect size, a standardized measure
of differences between treatment groups (Cohen, 1977). Veehof,
Trompetter, Bohlmeijer, and Schreurs (2016) conducted a metaanalysis consisting of 27 studies to determine the effectiveness of
acceptance and mindfulness-based interventions in treating chronic
pain. They found significant effect sizes for therapies designed to
reduce pain interference (of daily tasks) and for therapies designed to
reduce pain intensity. By contrast a meta-analysis of the effectiveness
https://scholarsarchive.byu.edu/intuition/vol12/iss2/6
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of CBT for chronic-pain performed by Williams, Eccleston, and Morley
(2012) resulted in small effect sizes for pain intensity, pain-inference,
and mood. Because this treatment treats both the interference and
the intensity of pain, research supports that mindfulness meditation
may be more effective in treating neuropathic pain than traditional
treatments such as CBT and pharmacotherapy.
A more direct comparison of mindfulness meditation to
pharmacotherapy can be seen in Kabat-Zinn and colleagues’ (1985)
study. They compared the outcomes in 90 chronic-pain patients who
were treated with mindfulness meditation with those in a comparable
group of patients who were treated with physical therapy, analgesics,
and antidepressants. In a 10-week follow-up, those in the former
group reported significant reductions in anxiety (65%), depression
(59%), hostility (57%), somatization (physical symptoms without
a known cause; 30%), and lack of self-esteem (45%), while those in
the latter group reported smaller reductions in the same measures
(29%, 18%, 7%, 0%, and 34%, respectively). Mindfulness meditation
therefore shows significant promise in treating neuropathic pain more
effectively than pharmacotherapy does.
Cultural Preference for Pharmacotherapy
Despite the demonstrated effectiveness of mindfulness meditation,
pharmacotherapy is still the most common treatment for neuropathic
pain (Dworkin et al., 2003). There are a number of reasons why this is
the case, many of which may be due to patient preferences. Patients
are more familiar with taking medication than they are with practicing
mindfulness meditation. This is likely because meditation is not a
common part of American culture and is usually associated with East
Asian cultures (Kabat-Zinn et al., 1985). Conserving time and energy
are also concerns; it is arguably much quicker and easier to take a pill
than to spend 45 min meditating every day (Kabat-Zinn et al., 1985).
The lack of physicians trained in mindfulness meditation is another
notable reason for a preference for pharmacotherapy (Baer, 2003).
These preferences indicate that, although scientific evidence supports
mindfulness meditation as a practical alternative, custom and social
preference still holds significant sway in favor of pharmacotherapy as
the treatment of choice for neuropathic pain.
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Conclusion
Mindfulness meditation is a form of treatment for neuropathic
pain that is focused on helping the patient accept the existence of
the pain while also limiting the pain’s interference with the patient’s
overall well-being (Kabat-Zinn et al., 1985). The evidence I have
reviewed supports mindfulness meditation as an acceptable, and
sometimes preferable, alternative to pharmacotherapy (Kabat-Zinn
et al., 1985; Veehof et al., 2016). The latter usually results in multiple
prescriptions that cause serious side effects and have diminished
effectiveness over time (Kingery, 1997; Trang et al., 2015). Mindfulness
meditation, however, is a more holistic approach, one that addresses
the psychological effects of neuropathic pain on the quality of life
(Pepping et al., 2016). Those who suffer from neuropathic pain should
be aware of both forms of treatments and their comparative benefits
and liabilities so that they can choose the best approach to not only
relieve their pain but also reduce its interference in living healthy,
meaningful lives.
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